Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro AsfiledCriticalNorsk Hydro As
Priority to MYPI89001437ApriorityCriticalpatent/MY105876A/en
Publication of MY105876ApublicationCriticalpatent/MY105876A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
ANTI-CANCER PLATINUM COMPLEXES SUCH AS CISPLATIN EXHIBIT A SYNERGISTICALLY HIGHER LEVEL OF ANTI-TUMOUR ACTIVITY WHEN ADMINISTERED SUBSTANTIALLY SIMULTANEOUSLY EITHER WITH L-ASCORBIC ACID, OR WITH 5,6-0-BENZYLIDENE-L-ASCORBIC ACID OR DEUTERATED FORMS THEREOF.
MYPI89001437A1989-10-191989-10-19Pharmaceutical compositions with anti-cancer activity and method for the treatment of cancer.
MY105876A
(en)
Process for production of celates and their complexes containing ortolizating functional groups, compositions containing such active substances and process for production of conjugates consisting of one complex and linked to it antibody or fragment of antibody
COMPLEXES WITH CYCLODEXTRINS INDICATED FOR THE TREATMENT OF ALL ANEMIC FORMS DUE TO FOLATE DEFICIENCY, THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS
New naphtiridin derivatives , preparation method, pharmaceutical compositions containing these derivatives, their utilization as antireproductive medicines